Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

M-CSF-stimulated myeloid cells can cause alopecia areata in mice.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

Wnt signaling controls whether hair follicle stem cells stay inactive or regenerate hair.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Proper control of β-catenin activity is crucial for development and preventing diseases like cancer.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Skin conditions can signal heart issues, highlighting the need for integrated care.

Genetically modified sheep with more β-catenin grew more wool without changing the wool's length or thickness.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

A 3-year-old boy lost all his hair due to a rare reaction to phenobarbital, but it grew back after steroid treatment.

A girl with severe hair loss saw hair regrowth after using cannabis.

IL-17-producing γδ T cells help improve bone healing.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

A deficiency in the TTC7A gene causes immune problems, gut issues, and hair loss.

Older skin has higher cancer risk due to inflammation and stem cell issues.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Blocking SCD1 in the skin with XEN103 shrinks sebaceous glands in mice.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.

T-cell reconstitution after thymus transplantation can cause hair whitening and loss.

Researchers found four genes that could help diagnose severe alopecia areata early.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Transforming skin disease treatment requires new strategies, better drug models, and patient-focused research.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.